This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
HealthdirectFree Australian health advice you can count on.
INN: DAUNORUBICIN (DAUNORUBICIN HYDROCHLORIDE)
Data updated: 2026-04-25
Available in:
🇬🇧🇸🇰
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
GENERIC MEDICAL PARTNERS INC
ATC Code
L01DB02
Source
DPD · 02501473
(
ARTG
)
INDICATIONS AS AT 22 NOVEMBER 2004 : Daunorubicin Injection is indicated for the treatment of the following: Acute lymphocytic (lymphoblastic) leukaemia: Daunorubicin is usually reserved for use in cases shown to be resistant to other drugs. However, combined treatment with daunorubicin, vincristine and a steroid has been used in the early stages of this disease. Acute myeloblastic leukaemia: Daunorubicin has been used in all stages, alone or in combination with other cytotoxic agents (e.g. cytarabine). Disseminated solid tumours: Daunorubicin has been investigated for use in these tumours and found to be effective in some cases of disseminated neuroblastoma and rhabdomyosarcoma.
